GlassScriptPhysician profile
Nicholas Michael Capito
NPI 1114238474
$83,342.96
in general payments reported to CMS, 2019-2025
32 companies · $10K in 2025
The $10K reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,319 · 2020: $1,455 · 2021: $8,483 · 2022: $15K · 2023: $16K · 2024: $29K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $51K · Food and Beverage: $2,713 · Travel and Lodging: $1,916.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $50,667.44 |
| Food and Beverage | $2,712.90 |
| Travel and Lodging | $1,915.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Orthoscience | $63,347.43 | 2021-2025 | Catalyst Csr Shoulder System, Catalyst Total Csr, R1 Reverse Shoulder System |
| Shoulder Innovations, INC. | $9,622.66 | 2020-2025 | Inset System |
| Medical Device Business Services, INC. | $4,236.24 | 2023 | Inhance |
| Wright Medical Technology, INC. | $2,769.62 | 2019 | |
| Encore Medical, LP | $1,349.78 | 2021-2023 | Djo Surgical |
| Smith+Nephew, INC. | $499.35 | 2023-2024 | Bone Anchors With Arthroscopic Delivery System, Evos, Evos Mini |
| Anika Therapeutics, INC. | $262.00 | 2023-2025 | Integrity, Sportsmed Portfolio, Integrity Implant |
| Biedermann Motech, INC. | $226.51 | 2019 | |
| Depuy Synthes Sales INC. | $140.98 | 2023-2024 | Inhance, Orthovisc, Monovisc |
| Skeletal Dynamics INC | $115.28 | 2024 | Align, Geminus, Ijs |
| Bioventus LLC | $106.34 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Acumed LLC | $94.34 | 2019 | |
| Convatec INC. | $75.18 | 2019-2022 | |
| Alafair Biosciences, INC. | $69.59 | 2019 | |
| Medtronic, INC. | $48.26 | 2022-2024 | Accurian |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $39.99 | 2023 | |
| Dynasplint Systems INC. | $37.97 | 2019 | |
| Endo Pharmaceuticals INC. | $36.42 | 2020-2022 | |
| Ermi LLC | $35.79 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $27.90 | 2025 | |
| Innovation Technologies INC | $25.54 | 2025 | Irrisept |
| Heraeus Medical, LLC. | $21.25 | 2019 | |
| Solventum Corporation | $20.53 | 2024 | Activ.A.C., Prevena Restor Arthroform |
| Avanos Medical | $18.79 | 2023 | Trivisc Sodium Hyaluronate |
| Zimmer Biomet Holdings, INC. | $16.66 | 2020 | |
| Heron Therapeutics, INC. | $14.84 | 2021 | |
| Horizon Therapeutics Plc | $14.82 | 2021 | |
| Boston Scientific Corporation | $14.80 | 2019 | |
| Amgen INC. | $14.80 | 2020 | |
| Vericel Corporation | $14.60 | 2021 | |
| Abbott Laboratories | $12.81 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $11.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Capito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.